AAP Endorses New Algorithm for Critical Congenital Heart Disease Screening
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 16, 2024 -- In a clinical report published online Dec. 16 in Pediatrics, the American Academy of Pediatrics endorses a new algorithm for use in critical congenital heart disease (CCHD) screening, which was added to the U.S. Recommended Uniform Screening Panel in 2011.
Matthew E. Oster, M.D., M.P.H., from Emory University School of Medicine in Atlanta, and colleagues present updated recommendations for CCHD screening since the 2011 AAP endorsement.
The authors note that a new AAP algorithm has been endorsed for use in CCHD screening. This new algorithm has a passing oxygen saturation threshold of ≥95 percent in pre- and post-ductal measurements and has only one retest for infants who do not pass the first screen, instead of two. To aid in surveillance and monitoring of the program and continue to improve screening, state newborn screening programs should collect a recommended minimum uniform dataset. Education on the limitations of screening, the significance of non-CCHD conditions, and the importance of adhering to protocol should be provided to stakeholders. Improving overall sensitivity and implementing methods to reduce health inequities are included as future directions of CCHD screening.
"The recommended changes to the algorithm simplify the screening process, potentially decreasing error rates in the interpretation of the algorithm and reducing the time to conduct a screening," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.